Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.38 |
| ▸ | ACACB | O00763 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.37 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17828391 | 1.00 | L3MBTL1 (0.43) | L3MBTL1ALDH1A1MEN1HPGDKMT2A | |
| SCHEMBL17828385 | 1.00 | L3MBTL1 (0.43) | L3MBTL1ALDH1A1MEN1HPGDKMT2A | |
| SCHEMBL17805702 | 0.84 | LTB4R (0.39) | L3MBTL1ALDH1A1CYSLTR1 | |
| SCHEMBL17805528 | 0.84 | LTB4R (0.39) | L3MBTL1ALDH1A1CYSLTR1 | |
| SCHEMBL17831481 | 0.84 | LTB4R (0.39) | L3MBTL1ALDH1A1CYSLTR1 | |
| SCHEMBL27794445 | 0.82 | L3MBTL1 (0.58) | L3MBTL1ALDH1A1MEN1KMT2ACHRM2 | |
| SCHEMBL1444565 | 0.82 | L3MBTL1 (0.58) | L3MBTL1ALDH1A1MEN1KMT2ACHRM2 | |
| SCHEMBL17796121 | 0.81 | ALOX5 (0.39) | L3MBTL1MEN1KMT2ACNR1PTGS1 | |
| SCHEMBL17796078 | 0.81 | ALOX5 (0.39) | L3MBTL1MEN1KMT2ACNR1PTGS1 | |
| SCHEMBL17796119 | 0.81 | ALOX5 (0.39) | L3MBTL1MEN1KMT2ACNR1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9676796-B2 | Tricyclic benzoxaborole compound, preparation method and use thereof | DONG-A ST CO., LTD. (KR) | 2017-06-13 | — | — | US | disclosed |
| US-20160168167-A1 | Tricyclic Benzoxaborole Compound, Preparation Method and Use Thereof | DONG-A ST CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168167-A1 | Tricyclic Benzoxaborole Compound, Preparation Method and Use Thereof | CYP2C19, CYP2C9, TBCB | L3MBTL1 4526/4885ALDH1A1 3448/4885MEN1 3134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.